Prognosticators and the role of lymphadenectomy in uterine leiomyosarcomas

Archives of Gynecology and Obstetrics

Volumn 280, Issue 1, 2009, Pages 79-85

  Ayhan, Ali ^a   Aksan, Guldeniz ^b   Gultekin, Murat ^c,d   Esin, Sertac ^b   Himmetoglu, Cigdem ^b   Dursun, Polat ^a   Usubutun, Alp ^b   Yuce, Kunter ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Cankiri Government Hospital   (Turkey)

^d Cankiri Devlet Hastanesi   (Turkey)

Author keywords

Adjuvant treatments; Disease free survival (DFS); Lymphadenectomy; Lymphatic metastasis; Overall survival (OS); Prognosis; Uterine sarcomas

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MITOSIS; NECROSIS; POSTOPERATIVE PERIOD; PROGNOSIS; RADIATION DOSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MIDDLE AGED; MITOSIS INDEX; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL; UTERUS CANCER;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LEIOMYOSARCOMA; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MITOTIC INDEX; MULTIVARIATE ANALYSIS; NECROSIS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 67649655989     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0876-0     Document Type: Article

References (31)

1. BL Harlow NS Weis S Lofton 1986 The epidemiology of sarcomas of the uterus J Natl Cancer Inst 76 399 402 (Pubitemid 16119773)
2. BA Goff LW Rice D Fleischhacker HG Muntz SS Falkenberry N Nikrui AF Fuller Jr 1993 Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence Gynecol Oncol 50 1 105 109 10.1006/gyno.1993.1172
3. G El Husseiny N Al Bareedy WA Mourad 2002 Prognostic factors and treatment modalities in uterine sarcoma Am J Clin Oncol 25 256 260 10.1097/00000421-200206000-00010 CCT
4. RR Nordal GB Kristensen J Kaern 1995 The prognostic significance of stage, tumour size, cellular atypia and DNA ploidy in uterine leiomyosarcoma Acta Oncol 34 797 802 10.3109/02841869509127189
5. SW Bell RL Kempson MR Hendrickson 1994 Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases Am J Surg Pathol 18 6 535 558 10.1097/00000478-199406000-00001 (Pubitemid 24150803)
6. JL Benedet H Bender H Jones III 2002 FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers Int J Gynaecol Obstet 70 209 262
7. HL Evans SP Chawla C Simpson KP Finn 1988 Smooth muscle neoplasm of the uterus other than ordinary leiomyoma: a study of 46 cases, with emphasis on diagnostic criteria and prognostic factor Cancer 62 2239 2247 10.1002/1097-0142(19881115)62:10<2239::AID-CNCR2820621028>3.0.CO;2-Y
8. JR Vardi HMM Tovell 1980 Leiomyosarcoma of the uterus: a clinicopathologic study Obstet Gynecol 56 428 434 (Pubitemid 10018300)
9. R Blom C Guerrieri O Stal H Malmstrom E Simonsen 1998 Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases Gynecol Oncol 68 54 61 10.1006/gyno.1997.4889
10. KV Kahanpaa T Wahlstrom P Grohn 1986 Sarcomas of the uterus: a clinicopathologic study of 119 patients Obstet Gynecol 67 417 424 (Pubitemid 16129989)
11. MJ Marchese AS Liskow CP Crum 1984 Uterine sarcomas: a clinicopathologic study, 1965-1981 Gynecol Oncol 18 299 312 10.1016/0090-8258(84)90041-6 (Pubitemid 14095029)
12. B Larson C Silfversward B Nilsson F Petterson 1990 Prognostic factors in uterine leiomyosarcoma: a clinicopathologic study of 143 cases. The Radiumhemmet series, 1936-1981 Acta Oncol 29 185 191 10.3109/02841869009126543 (Pubitemid 20145283)
13. WR Hart JK Billman Jr 1978 A reassessment of uterine neoplasm originally diagnosed as leiomyosarcomas Cancer 41 1902 1910 10.1002/1097-0142(197805)41: 5<1902::AID-CNCR2820410535>3.0.CO;2-K
14. K Mayerhofer A Obermair G Windbichler 1999 Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases Gynecol Oncol 74 196 201 10.1006/gyno.1999.5436
15. P Pautier C Genmestie A Rey 2000 Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 88 1425 1431 10.1002/(SICI)1097-0142(20000315)88: 6<1425::AID-CNCR21>3.0.CO;2-3
16. LJ Layfield K Liu R Dodge SH Barsky 2000 Uterine smooth muscle tumor. Utility of classification by proliferation, ploidy and prognostic markers versus traditional histopathology Arch Pathol Lab Med 124 2 221 227 (Pubitemid 30090606)
17. MW Kattan DH Leung MF Brennan 2002 Postoperative nomogram for 12-year sarcoma-specific death J Clin Oncol 20 791 796 10.1200/JCO.20.3.791
18. RL Giuntoli 2nd DS Metzinger CS DiMarco SS Cha JA Sloan GL Keeney BS Gostout 2003 Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy Gynecol Oncol 89 3 460 469 10.1016/S0090-8258(03)00137-9
19. TI Wu TC Chang S Hsueh KH Hsu HH Chou HJ Huang CH Lai 2006 Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma Gynecol Oncol 100 1 166 172 10.1016/j.ygyno.2005.08.010
20. K Bodner B Bodner-Adler O Kimberger 2003 Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study J Reprod Med 48 95 100 (Pubitemid 36249753)
21. CH Hsieh H Lin CC Huang 2003 Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases Acta Obstet Gynecol Scand 82 74 81 10.1034/j.1600-0412.2003.820114.x
22. MM Leitao Y Sonoda MF Brennan RR Barakat DS Chi 2003 Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus Gynecol Oncol 91 1 209 212 10.1016/S0090-8258(03)00478-5
23. TA Dinh EA Oliva AF Fuller Jr H Lee A Goodman 2004 The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital Gynecol Oncol 92 2 648 652 10.1016/j.ygyno.2003. 10.044
24. F Moinfar M Azodi FA Tavassoli 2007 Uterine sarcomas Pathology 39 1 55 71 10.1080/00313020601136146
25. FJ Major JA Blessing SG Silverberg 1993 Prognostic factors in early stage uterine sarcoma Cancer 71 1902 1909
26. TV Dinh JD Woodruff 1982 Leiomyosarcoma of the uterus Am J Obstet Gynecol 144 7 817 823 (Pubitemid 13196596)
27. SS Chen 1989 Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus Gynecol Oncol 32 215 217 10.1016/S0090-8258(89)80035-6
28. A Gadducci F Landoni E Sartori P Zola T Maggino A Lissoni L Bazzurini R Arisio C Romagnolo R Cristofani 1996 Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 25 32 10.1006/gyno.1996.0185
29. GB Gard NJ Mulvany MA Quinn 1999 Management of uterine leiomyosarcoma in Australia Aust N Z J Obstet Gynaecol 39 1 93 98 10.1111/j.1479-828X.1999. tb03039.x (Pubitemid 29108194)
30. D Leibsohn G d'Ablaing DR Mishrll Jr JB Schlaerth 1990 Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas Am J Obstet Gynecol 162 968 974
31. DS Kapp JY Shin JK Chan 2008 Prognostic factors and survival in 1,396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 4 820 830 10.1002/cncr.23245